Biogen Pharma

Market Cap: Micro Cap
Industry: Trading
ISIN: INE703D01023
NSEID:
BSEID: 531752

INR

0.94

0.02 (2.17%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.15 lacs

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Jun'23

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is -616.67% vs -80.00% in Dec 2023

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is -1,700.00% vs -109.68% in Dec 2023

Interest

YoY Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023

Compare Quarterly Results Of Biogen Pharma With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

0.00

145.25

-145.25

-100.00%

Other Operating Income

0.00

Total Operating income

0.00

145.25

-145.25

-100.00%

Raw Material Cost

0.00

Purchase of Finished goods

0.00

130.28

-130.28

-100.00%

(Increase) / Decrease In Stocks

0.00

0.72

-0.72

-100.00%

Employee Cost

0.05

1.15

-1.10

-95.65%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

0.49

6.15

-5.66

-92.03%

Total Expenditure (Excl Depreciation)

0.54

138.30

-137.76

-99.61%

Operating Profit (PBDIT) excl Other Income

-0.54

6.95

-7.49

-107.77%

Other Income

0.23

1.04

-0.81

-77.88%

Operating Profit (PBDIT)

-0.31

7.99

-8.30

-103.88%

Interest

0.00

0.22

-0.22

-100.00%

Exceptional Items

0.00

Gross Profit (PBDT)

-0.31

7.77

-8.08

-103.99%

Depreciation

0.00

0.05

-0.05

-100.00%

Profit Before Tax

-0.31

7.72

-8.03

-104.02%

Tax

0.00

2.77

-2.77

-100.00%

Provisions and contingencies

0.00

Profit After Tax

-0.31

4.95

-5.26

-106.26%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

-0.31

4.95

-5.26

-106.26%

Equity Capital

65.26

85.86

-20.60

-23.99%

Face Value

1.00

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

-0.00

0.58

-0.58

-100.00%

Diluted Earnings per share

-0.01

0.57

-0.58

-101.75%

Operating Profit Margin (Excl OI)

0.00%

4.78%

0.00

-4.78%

Gross Profit Margin

0.00%

5.35%

0.00

-5.35%

PAT Margin

0.00%

3.41%

0.00

-3.41%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

No Net Sales in the last few periods

QoQ Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit -0.31 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 69.00% vs -525.00% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -616.67% vs -80.00% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) -0.54 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -54.29% vs -118.75% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -1,700.00% vs -109.68% in Dec 2023

Quarterly - Interest

No Interest in the last few periods

QoQ Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

No Operating Profit Margin (Excl OI) in the last few periods

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023